Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
Bolt Biotherapeutics (BOLT)
- 4.730
- -0.080-1.66%
Close Apr 17 16:00 ET
- 4.730
- 0.0000.00%
Post 20:01 ET
9.09MMarket Cap-0.26P/E (TTM)
4.940High4.710Low9.16KVolume4.800Open4.810Prev Close44.43KTurnover0.52%Turnover RatioLossP/E (Static)1.92MShares9.24852wk High0.34P/B8.38MFloat Cap3.91052wk Low--Dividend TTM1.77MShs Float861.400Historical High--Div Yield TTM4.78%Range %3.910Historical Low4.851Avg Price1Lot Size
Bolt Biotherapeutics (BOLT) Key Financial Indicators
BOLT Earnings per Share (EPS)
According to the latest financial report of Bolt Biotherapeutics, the latest earnings per share (TTM) for the company is -3.84. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
BOLT Free Cash Flow (FCF)
Interested in knowing about Bolt Biotherapeutics's free cash flow? The latest report shows it as -7.16M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
BOLT Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Bolt Biotherapeutics shows that the company's current ratio is 3.59, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
BOLT Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Bolt Biotherapeutics, the quick ratio is 3.38, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
BOLT Return on Equity (ROE)
Want to learn more about the financial health of Bolt Biotherapeutics? The latest ROE figure is -22.63%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
BOLT Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Bolt Biotherapeutics, the total asset return on investment (ROA) is -10.89%.
Currency: USD
Quarterly
Loading...
BOLT Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Bolt Biotherapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
BOLT Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Bolt Biotherapeutics, the net profit margin is -265.24%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm